These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 39161621)

  • 1. Synergistic combination of RAD51-SCR7 improves CRISPR-Cas9 genome editing efficiency by preventing R-loop accumulation.
    Park SJ; Park SJ; Kwon YW; Choi EH
    Mol Ther Nucleic Acids; 2024 Sep; 35(3):102274. PubMed ID: 39161621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency.
    Park SJ; Yoon S; Choi EH; Hyeon H; Lee K; Kim KP
    BMB Rep; 2023 Feb; 56(2):102-107. PubMed ID: 36513383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells.
    Hu Z; Shi Z; Guo X; Jiang B; Wang G; Luo D; Chen Y; Zhu YS
    Cell Biosci; 2018; 8():12. PubMed ID: 29468011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein.
    Ma Y; Chen W; Zhang X; Yu L; Dong W; Pan S; Gao S; Huang X; Zhang L
    RNA Biol; 2016 Jul; 13(7):605-12. PubMed ID: 27163284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing.
    Vartak SV; Raghavan SC
    FEBS J; 2015 Nov; 282(22):4289-94. PubMed ID: 26290158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated epigenetic editing tool: An optimized strategy for targeting de novo DNA methylation with stable status via homology directed repair pathway.
    Wang J; Li D; Yang J; Chang L; Zhang R; Li J
    Biochimie; 2022 Nov; 202():190-205. PubMed ID: 35921985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 assisted non-homologous end joining genome editing system of Halomonas bluephagenesis for large DNA fragment deletion.
    Liu C; Yue Y; Xue Y; Zhou C; Ma Y
    Microb Cell Fact; 2023 Oct; 22(1):211. PubMed ID: 37838676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of the FecG
    Xu X; Zhang X; Peng X; Liu C; Li W; Liu M
    Theriogenology; 2023 Feb; 197():177-185. PubMed ID: 36525857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized CRISPR-Cas9 Genome Editing for
    Zhang WW; Lypaczewski P; Matlashewski G
    mSphere; 2017; 2(1):. PubMed ID: 28124028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining.
    Manjunath M; Choudhary B; Raghavan SC
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1341. PubMed ID: 33496064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
    Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
    Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between DNA mismatch repair and CRISPR/Cas9-mediated knock-in in the bovine β-casein gene locus.
    Kim SY; Kim GY; You HJ; Kang MJ
    Anim Biosci; 2022 Jan; 35(1):126-137. PubMed ID: 34293843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7.
    Anuchina AA; Zaynitdinova MI; Demchenko AG; Evtushenko NA; Lavrov AV; Smirnikhina SA
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells.
    Li Y; Lian D; Wang J; Zhao Y; Li Y; Liu G; Wu S; Deng S; Du X; Lian Z
    Mol Ther Nucleic Acids; 2023 Mar; 31():309-323. PubMed ID: 36726409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient and modular CRISPR-Cas9 vector system for
    Mallett DR; Chang M; Cheng X; Bezanilla M
    Plant Direct; 2019 Sep; 3(9):e00168. PubMed ID: 31523744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHEJ inhibitor SCR7 and its different forms: Promising CRISPR tools for genome engineering.
    Ray U; Vartak SV; Raghavan SC
    Gene; 2020 Dec; 763():144997. PubMed ID: 32783992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-AAV Mediated Knock-in at NRL Locus in Human Embryonic Stem Cells.
    Ge X; Xi H; Yang F; Zhi X; Fu Y; Chen D; Xu RH; Lin G; Qu J; Zhao J; Gu F
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e393. PubMed ID: 27898094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
    Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL
    Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.